BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25056396)

  • 1. Prioritized current unmet needs for antibacterial therapies.
    Spellberg B; Shlaes D
    Clin Pharmacol Ther; 2014 Aug; 96(2):151-3. PubMed ID: 25056396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial drug development: challenges, recent developments, and future considerations.
    Nambiar S; Laessig K; Toerner J; Farley J; Cox E
    Clin Pharmacol Ther; 2014 Aug; 96(2):147-9. PubMed ID: 25056394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unmet medical needs in antibacterial therapy.
    Rice LB
    Biochem Pharmacol; 2006 Mar; 71(7):991-5. PubMed ID: 16280121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ; Bradford PA
    Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whither antibacterial drug discovery?
    Projan SJ
    Drug Discov Today; 2008 Apr; 13(7-8):279-80. PubMed ID: 18405838
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of antibiotic management on resistance.
    Bosso JA
    Pharmacotherapy; 2004 Dec; 24(12 Pt 2):224S-31S. PubMed ID: 15585452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges of antibacterial discovery revisited.
    Gwynn MN; Portnoy A; Rittenhouse SF; Payne DJ
    Ann N Y Acad Sci; 2010 Dec; 1213():5-19. PubMed ID: 21058956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future challenges facing the development of new antimicrobial drugs.
    Coates A; Hu Y; Bax R; Page C
    Nat Rev Drug Discov; 2002 Nov; 1(11):895-910. PubMed ID: 12415249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on antibacterial and antifungal drugs - can we master the resistance crisis?
    Theuretzbacher U; Mouton JW
    Curr Opin Pharmacol; 2011 Oct; 11(5):429-32. PubMed ID: 21903474
    [No Abstract]   [Full Text] [Related]  

  • 10. Mathematical analysis of multi-antibiotic resistance.
    Zhao B; Zhang X
    Int J Cardiol; 2016 Sep; 219():33-7. PubMed ID: 27262230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic Adjuvants: Rescuing Antibiotics from Resistance.
    Wright GD
    Trends Microbiol; 2016 Nov; 24(11):862-871. PubMed ID: 27430191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of pharmacodynamic research in the assessment and development of new antibacterial drugs.
    Lister PD
    Biochem Pharmacol; 2006 Mar; 71(7):1057-65. PubMed ID: 16316633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents.
    Payne D; Tomasz A
    Curr Opin Microbiol; 2004 Oct; 7(5):435-8. PubMed ID: 15451496
    [No Abstract]   [Full Text] [Related]  

  • 14. There should be no ESKAPE for febrile neutropenic cancer patients: the dearth of effective antibacterial drugs threatens anticancer efficacy.
    Bow EJ
    J Antimicrob Chemother; 2013 Mar; 68(3):492-5. PubMed ID: 23299574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The need for new antibiotics.
    Livermore DM
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():1-9. PubMed ID: 15522034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial resistance: an overview.
    Kushwah A; Gandhe M; Patel P
    J Indian Med Assoc; 2013 Apr; 111(4):260-3. PubMed ID: 24475559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved treatment of multidrug-resistant bacterial infections: utility of clinical studies.
    Bettiol E; Rottier WC; Del Toro MD; Harbarth S; Bonten MJ; Rodríguez-Baño J;
    Future Microbiol; 2014; 9(6):757-71. PubMed ID: 25046523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of genomics to select antibacterial targets.
    Pucci MJ
    Biochem Pharmacol; 2006 Mar; 71(7):1066-72. PubMed ID: 16412986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in antibacterial therapy against emerging bacterial pathogens.
    Pournaras S; Iosifidis E; Roilides E
    Semin Hematol; 2009 Jul; 46(3):198-211. PubMed ID: 19549574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.